Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 290

    1.

    Summaries for patients. Benefits of lowering cholesterol levels in older patients.

    [No authors listed]

    Ann Intern Med. 2001 May 15;134(10):S-4. No abstract available. PMID: 11357858 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.

    Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, Lane G, Tonkin A.

    Ann Intern Med. 2001 May 15;134(10):931-40.PMID: 11352694 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).

    Lim PO, Yee KM.

    Circulation. 1999 Aug 10;100(6):686. No abstract available. PMID: 10441109 [PubMed - indexed for MEDLINE]Related articles

    4.

    Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

    Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.

    Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C.PMID: 12646338 [PubMed - indexed for MEDLINE]Related articles

    5.

    Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

    JAMA. 2002 Dec 18;288(23):2998-3007.PMID: 12479764 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?

    Deedwania PC.

    Geriatrics. 2000 May;55(5):22-8. Review.PMID: 10826262 [PubMed - indexed for MEDLINE]Related articles

    7.

    In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?

    Adelman A.

    J Fam Pract. 2001 Nov;50(11):924. No abstract available. PMID: 11711002 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.

    Hague W, Forder P, Simes J, Hunt D, Tonkin A; LIPID Investigators.

    Am Heart J. 2003 Apr;145(4):643-51.PMID: 12679760 [PubMed - indexed for MEDLINE]Related articles

    9.

    A comparison of continuous combined hormone replacement therapy, HMG-CoA reductase inhibitor and combined treatment for the management of hypercholesterolemia in postmenopausal women.

    Ozsener S, Sendag F, Koc T, Terek MC, Oztekin K, Bilgin O.

    J Obstet Gynaecol Res. 2001 Dec;27(6):353-8.PMID: 11794823 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.

    Elam MB, Cushman W, Applegate WB, Heimberg M.

    Tenn Med. 1997 May;90(5):189-92. No abstract available. PMID: 9130876 [PubMed - indexed for MEDLINE]Related articles

    11.

    Updated guidelines support even lower cholesterol levels for at-risk patients.

    Levenson D.

    Rep Med Guidel Outcomes Res. 2004 Aug 6;15(15):1, 6-7. No abstract available. PMID: 15320342 [PubMed - indexed for MEDLINE]Related articles

    12.

    Long-term follow-up of the West of Scotland Coronary Prevention Study.

    DeFilippis AP, Bansal S, Blumenthal RS.

    N Engl J Med. 2008 Jan 10;358(2):194; author reply 194-5. No abstract available. PMID: 18193527 [PubMed - indexed for MEDLINE]Related articles

    13.

    Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease).

    Lancet. 2002 Apr 20;359(9315):1379-87. Erratum in: Lancet 2002 Nov 2;360(9343):1430. PMID: 11978335 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly]

    [No authors listed]

    MMW Fortschr Med. 2005 Aug 18;147(33-34):50-1. German. No abstract available. PMID: 16138640 [PubMed - indexed for MEDLINE]Related articles

    15.

    More on PROSPER.

    Baztán JJ, Hornillos M, Rodríguez-Mañas L.

    Lancet. 2003 Mar 29;361(9363):1135; author reply 1136. No abstract available. PMID: 12672345 [PubMed - indexed for MEDLINE]Related articles

    16.

    Who should receive statin therapy among the elderly?

    Desilvey DL.

    Am J Geriatr Cardiol. 2006 Mar-Apr;15(2):122. No abstract available. PMID: 16525228 [PubMed - indexed for MEDLINE]Related articles

    17.

    Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.

    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.

    Int J Cardiol. 2005 Oct 10;104(3):338-45.PMID: 16186066 [PubMed - indexed for MEDLINE]Related articles

    18.

    Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.

    Rader DJ, Davidson MH, Caplan RJ, Pears JS.

    Am J Cardiol. 2003 Mar 6;91(5A):20C-23C; discussion 23C-24C.PMID: 12646340 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lipid-lowering therapy and risk of coronary events.

    Blakely JA.

    JAMA. 2003 Apr 23-30;289(16):2070-1; author reply 2071-2. No abstract available. PMID: 12709461 [PubMed - indexed for MEDLINE]Related articles

    20.

    Lipid-lowering therapy and risk of coronary events.

    Mascitelli L, Pezzetta F.

    JAMA. 2003 Apr 23-30;289(16):2071; author reply 2071-2. No abstract available. PMID: 12709464 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data